Isolation limb perfusion with tumor necrosis factor alpha and chemotherapy for advanced extremity soft tissue sarcomas

被引:0
|
作者
Eggermont, AMM
Koops, HS
Klausner, JM
Lienard, D
Kroon, BBR
Schlag, PM
BenAri, G
Lejeune, FJ
机构
[1] CHU VAUDOIS,CTR PLURIDISCIPLINAIRE ONCOL,CH-1011 LAUSANNE,SWITZERLAND
[2] UNIV ROTTERDAM HOSP,DANIEL DEN HOED CANC CTR,ROTTERDAM,NETHERLANDS
[3] ACAD HOSP GRONINGEN,GRONINGEN,NETHERLANDS
[4] ICHILOV HOSP,IL-64239 TEL AVIV,ISRAEL
[5] HET NETHERLANDS KANKER INST,AMSTERDAM,NETHERLANDS
[6] UMBOLDT UNIV,ROBERT ROSSLE HOSP,BERLIN,GERMANY
[7] CHAIM SHEBA MED CTR,IL-52621 TEL HASHOMER,ISRAEL
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:547 / 555
页数:9
相关论文
共 50 条
  • [1] Tumor necrosis factor α and melfalan-based hyperthermic isolated limb perfusion in locally advanced extremity soft tissue sarcomas and melanomas
    Farre Alegre, Jose
    Duarte, Maritza
    Sureda Gonzalez, Manuel
    Bretcha Boix, Pere
    Dussan, Carlos
    Ballester, Antonio
    Crespo, Aurora
    Brugarolas Masllorens, Antonio
    [J]. CIRUGIA ESPANOLA, 2012, 90 (02): : 114 - 120
  • [2] Long-Term Results of Tumor Necrosis Factor α- and Melphalan-Based Isolated Limb Perfusion in Locally Advanced Extremity Soft Tissue Sarcomas
    Deroose, Jan P.
    Eggermont, Alexander M. M.
    van Geel, Albertus N.
    Burger, Jacobus W. A.
    den Bakker, Michael A.
    de Wilt, Johannes H. W.
    Verhoef, Cornelis
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (30) : 4036 - 4044
  • [3] Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas - The cumulative multicenter European experience
    Eggermont, AMM
    Koops, HS
    Klausner, JM
    Kroon, BBR
    Schlag, PM
    Lienard, D
    vanGeel, AN
    Hoekstra, HJ
    Meller, I
    Nieweg, OE
    Kettelhack, C
    BenAri, G
    Pector, JC
    Lejeune, FJ
    [J]. ANNALS OF SURGERY, 1996, 224 (06) : 756 - 765
  • [4] Treatment modifications in tumour necrosis factor-α (TNF)-based isolated limb perfusion in patients with advanced extremity soft tissue sarcomas
    Deroose, Jan P.
    Grunhagen, Dirk J.
    de Wilt, Johannes H. W.
    Eggermont, Alexander M. M.
    Verhoef, Cornelis
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 (03) : 367 - 373
  • [5] Hyperthermic isolated limb perfusion with tumor necrosis factor-α and melphalan in advanced soft-tissue sarcomas:: Histopathological considerations
    Issakov, J
    Merimsky, O
    Gutman, M
    Kollender, Y
    Lev-Chelouche, D
    Abu-Abid, S
    Lifschitz-Mercer, B
    Inbar, M
    Klausner, JM
    Meller, I
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2000, 7 (02) : 155 - 159
  • [6] Hyperthermic Isolated Limb Perfusion With Tumor Necrosis Factor-α and Melphalan in Advanced Soft-Tissue Sarcomas: Histopathological Considerations
    Josephine Issakov
    Ofer Merimsky
    Mordechai Gutman
    Yehuda Kollender
    Dina Lev-Chelouche
    Soubhi Abu-Abid
    Beatriz Lifschitz-Mercer
    Moshe Inbar
    Joseph M. Klausner
    Isaac Meller
    [J]. Annals of Surgical Oncology, 2000, 7 : 155 - 159
  • [7] Role of isolated limb perfusion with recombinant human tumor necrosis factor and melphalan in locally advanced extremity soft tissue sarcoma
    Jakob, Jens
    Hohenberger, Peter
    [J]. CANCER, 2016, 122 (17) : 2624 - 2632
  • [8] Isolated limb perfusion with melphalan and tumor necrosis factor α for advanced melanoma and soft-tissue sarcoma
    Hayes, Andrew J.
    Neuhaus, Susan J.
    Clark, Matthew A.
    Thomas, J. Meirion
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (01) : 230 - 238
  • [9] Isolated Limb Perfusion With Melphalan and Tumor Necrosis Factor α for Advanced Melanoma and Soft-Tissue Sarcoma
    Andrew J. Hayes
    Susan J. Neuhaus
    Matthew A. Clark
    J. Meirion Thomas
    [J]. Annals of Surgical Oncology, 2007, 14 : 230 - 238
  • [10] Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: A multicenter trial
    Eggermont, AMM
    Koops, HS
    Lienard, D
    Kroon, BBR
    vanGeel, AN
    Hoekstra, HJ
    Lejeune, FJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (10) : 2653 - 2665